Auxiliary liver transplantation has been performed in the baboon using
allografts (n=8) and concordant xenografts hom donor African green mo
nkeys (n=8). The native portal vein was ligated in all cases and the n
ative common bile duct was ligated in 5 cases. The immunosuppressive t
herapy used was identical in both the allografts and xenografts and co
nsisted of triple drug therapy (cyclosporine, cyclophosphamide, and me
thylprednisolone), all at dosages consistent with clinical use, During
the determination of the surgical technique to be applied, there were
5 early failures (3 allografts, 2 xenografts), and 2 deaths at 10 and
20 days from multiorgan failure and sepsis, respectively (xenografts)
, The remaining 9 baboons (5 allografts, 4 xenografts) were electively
euthanized at 16-62 days (allografts) and 35-120 days (xenografts). H
yperacute rejection or antibody-mediated rejection was not seen in the
grafted livers, Episodes of acute cellular rejection occurred in the
majority of animals within the first 30 days and recurred in the longe
r-term survivors, but could be controlled by bolus therapy with intrav
enous methylprednisolone. Satisfactory donor liver function was confir
med using a number of tests, including scintigraphy in 3 cases. We con
clude that auxiliary liver transplantation using a closely related don
or species is feasible in baboons and might be extended to humans with
terminal liver failure, A baboon-to-man auxiliary liver graft may ser
ve as a ''bridge'' until either a human cadaver donor liver became ava
ilable or native liver function recovers in patients with fulminant he
patic failure.